Literature DB >> 6295953

Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination).

J Holmgren, A M Svennerholm, M Lindblad.   

Abstract

The two biotypes of Vibrio cholerae were found to have cell-associated hemagglutinins which differ with regard to binding to different species of erythrocytes and inhibition by monosaccharides. A total of 12 classical V. cholerae strains (Inaba or Ogawa) strongly agglutinated human erythrocytes in a reaction specifically inhibited by L-fucose, whereas 12 El Tor strains preferably agglutinated chicken erythrocytes, a reaction reversed by D-mannose or by higher concentrations of D-fructose, D-glucose, alpha-methyl-D-mannoside, or sucrose. Milk from Swedish women inhibited both of these adherence reactions, and the predominating inhibitory activity for each reaction resisted boiling, was destroyed by periodate treatment, and bound a concanavalin A-Sepharose column, suggesting a carbohydrate structure. Further characterization indicated that the inhibitory activity for classical V. cholerae hemagglutination was distributed about equally on glycoprotein and free oligosaccharide, but was not present on glycolipid. The El Tor inhibiting activity, on the other hand, was almost exclusively of a high-molecular-weight glycoprotein nature. These results support our previous suggestion (Holmgren et al., Infect. Immun. 33:136-141, 1981) that human milk may contain receptor-like glycocompounds which can prevent bacterial adherence by competition with receptors on target cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295953      PMCID: PMC347917          DOI: 10.1128/iai.39.1.147-154.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity.

Authors:  G W Jones; G D Abrams; R Freter
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes.

Authors:  G W Jones; R Freter
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

3.  Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.

Authors:  W Chaicumpa; N Atthasisiha
Journal:  Southeast Asian J Trop Med Public Health       Date:  1977-03       Impact factor: 0.267

Review 4.  Breast milk and defence against infection in the newborn.

Authors:  L A Hanson; J Winberg
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

Review 5.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

6.  Mannose-sensitive haemagglutinins in adherence of Vibrio cholerae eltor to intestine.

Authors:  J W Bhattacharjee; B S Srivastava
Journal:  J Gen Microbiol       Date:  1978-08

Review 7.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

Review 8.  Breast-feeding: second thoughts.

Authors:  J W Gerrard
Journal:  Pediatrics       Date:  1974-12       Impact factor: 7.124

9.  A procedure for the quantitative isolation of brain gangliosides.

Authors:  L Svennerholm; P Fredman
Journal:  Biochim Biophys Acta       Date:  1980-01-18

10.  Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae.

Authors:  J Holmgren; A M Svennerholm; C Ahrén
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more
  20 in total

1.  Vibrio cholerae O1 adherence to villi and lymphoid follicle epithelium: in vitro model using formalin-treated human small intestine and correlation between adherence and cell-associated hemagglutinin levels.

Authors:  T Yamamoto; T Kamano; M Uchimura; M Iwanaga; T Yokota
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis.

Authors:  M Mouricout; J M Petit; J R Carias; R Julien
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  Carbohydrate phenotyping of human and animal milk glycoproteins.

Authors:  Anki Gustafsson; Imre Kacskovics; Michael E Breimer; Lennart Hammarström; Jan Holgersson
Journal:  Glycoconj J       Date:  2005-03       Impact factor: 2.916

Review 4.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

5.  Bovine milk inhibits both adhesion of Helicobacter pylori to sulfatide and Helicobacter pylori-induced vacuolation of vero cells.

Authors:  Y Hata; T Kita; M Murakami
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  Molecular cloning and expression in Escherichia coli K-12 of the gene for a hemagglutinin from Vibrio cholerae.

Authors:  V L Franzon; P A Manning
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 7.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

8.  Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.

Authors:  A M Svennerholm; M M Levine; J Holmgren
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.

Authors:  J Osek; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

Authors:  R E Black; M M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.